Kezar Life Sciences Inc KZR:NASDAQ

Last Price$9.29NASDAQ Previous Close - Last Trade as of 4:00PM ET 7/01/22

Today's Change+1.02(12.33%)
Bid (Size)$9.24 (1)
Ask (Size)$9.34 (13)
Day Low / High$8.10 - 9.50
Volume3.7 M
 

View Biotechnology IndustryPeer Comparison as of 07/01/2022

 

Kezar Life Sciences Inc ( NASDAQ )

Price: $9.29
Change: +1.02 (12.33%)
Volume: 3.7 M
4:00PM ET 7/01/2022
 
 

AnaptysBio Inc ( NASDAQ )

Price: $20.47
Change: +0.17 (0.84%)
Volume: 191.0 K
4:00PM ET 7/01/2022
 
 

ANI Pharmaceuticals Inc ( NASDAQ )

Price: $31.54
Change: +1.86 (6.29%)
Volume: 106.3 K
4:00PM ET 7/01/2022
 
 

Stoke Therapeutics Inc ( NASDAQ )

Price: $13.77
Change: +0.56 (4.24%)
Volume: 171.3 K
4:00PM ET 7/01/2022
 
 

Rapt Therapeutics Inc ( NASDAQ )

Price: $18.07
Change: -0.18 (0.99%)
Volume: 132.1 K
4:00PM ET 7/01/2022
 

Read more news Recent News

Sector Update: Health Care Stocks Decline Tuesday but Largely Outperform Most Other Sectors
4:00PM ET 6/28/2022 MT Newswires

Health care stocks still were mostly lower this afternoon, with the NYSE Health Care Index and the SPDR Health Care Select Sector ETF (XLV) both falling...

Sector Update: Health Care Stocks Lower in Afternoon Trade
2:03PM ET 6/28/2022 MT Newswires

Health care stocks were mostly lower this afternoon, with the NYSE Health Care Index falling 1.6% and the SPDR Health Care Select Sector ETF (XLV) slipping...

Top Midday Gainers
1:56PM ET 6/28/2022 MT Newswires

Kezar Life Sciences (KZR) said a phase 2 clinical trial evaluating zetomipzomib for active lupus nephritis, a kidney inflammation, showed that 11 of 17...

Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday
9:17AM ET 6/28/2022 MT Newswires

Health care stocks were mixed pre-bell Tuesday. The Health Care SPDR (XLV) was up 0.42%, and the iShares NASDAQ Biotechnology Index (IBB) was recently...

View all Commentary and Analysis

Insider Weekends: Return Of The Meme Stocks - GameStop And AMC Entertainment
8:53AM ET 3/28/2022 Seeking Alpha

Kezar Life Sciences (KZR) Corporate Overview
4:03PM ET 9/10/2021 Seeking Alpha

Company Profile

Business DescriptionKezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer in South San Francisco and California. Its product pipeline include KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 20, 2015 and is headquartered in South San Francisco, CA. View company web site for more details
Address4000 Shoreline Court
South San Francisco, California 94080
Phone+1.650.822.5600
Number of Employees24
Recent SEC Filing06/27/20224
Chief Executive Officer & DirectorJohn Fowler
President, Director & Chief Scientific OfficerChristopher J. Kirk
Director-Finance & Business OperationsMichael Wolfe
Chief Financial Officer & SecretaryMarc L. Belsky

Company Highlights

Price Open$8.21
Previous Close$8.27
52 Week Range$4.31 - 18.55
Market Capitalization$561.3 M
Shares Outstanding60.4 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement08/11/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.05
Beta vs. S&P 500N/A
Revenue$0.00
Net Profit MarginN/A
Return on Equity-33.99%

Analyst Ratings as of 06/27/2022

Buy
6
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset